Atıf İçin Kopyala
Samia P., Oyieke K., Tunje D., Udwadia-Hegde A., Feemster K., Anlar B., ...Daha Fazla
CURRENT TREATMENT OPTIONS IN NEUROLOGY, cilt.24, sa.3, ss.99-110, 2022 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
24
Sayı:
3
-
Basım Tarihi:
2022
-
Doi Numarası:
10.1007/s11940-022-00710-x
-
Dergi Adı:
CURRENT TREATMENT OPTIONS IN NEUROLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
-
Sayfa Sayıları:
ss.99-110
-
Anahtar Kelimeler:
Treatment, Antiviral agent, Subacute sclerosing panencephalitis, Measles complication, SSPE, MEASLES-VIRUS, INTRAVENTRICULAR INTERFERON, SSPE, EPIDEMIOLOGY, IMMUNIZATION, VACCINATION, INOSIPLEX, DISEASE, PATIENT, ALPHA
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Purpose of the review Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and frequently fatal neurodegenerative disorder caused by measles virus. The risk of SSPE remains significant globally, with fluctuating incidence noted in in tandem with measles vaccine uptake. This review aims to explore the current global status of SSPE, its treatment, and preventive measures.